Quality-of-life (QoL) in RANGE: A phase 3 study of ramucirumab (RAM) plus docetaxel (DOC) versus placebo (P) plus DOC in platinum-refractory locally advanced or metastatic urothelial carcinoma (UC) Meeting Abstract
| Authors: | Necchi, A.; Nishiyama, H.; Matsubara, N.; Lee, J. L.; Petrylak, D. P.; De Wit, R.; Drakaki, A.; Liepa, A. M.; Zimmermann, A.; Bell-McGuinn, K. M.; Powles, T. |
| Abstract Title: | Quality-of-life (QoL) in RANGE: A phase 3 study of ramucirumab (RAM) plus docetaxel (DOC) versus placebo (P) plus DOC in platinum-refractory locally advanced or metastatic urothelial carcinoma (UC) |
| Meeting Title: | 2018 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2018 Feb 8-10 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-20 |
| Language: | English |
| ACCESSION: | WOS:000436179500413 |
| DOI: | 10.1200/JCO.2018.36.6_suppl.419 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 419 -- Source: Wos |
